Clinical use and safety of a novel gentamicin-releasing resorbable bone graft substitute in the treatment of osteomyelitis/osteitis

Bone and Joint Research

Volumn 3, Issue 7, 2014, Pages 223-229

  Fleiter, N ^a   Walter, G ^a   Bosebeck H ^a,b   Vogt, S ^a,b   Buchner H ^a,b   Hirschberger, W ^a,c   Hoffmann, R ^a  

^a Berufsgenossenschaftliche Unfallklinik Frankfurt am Main   (Germany)

^b Heraeus Medical ^*  (Germany)

^c Hirschberger and Partner   (Germany)

Author keywords

Calcium sulfate; Gentamicin; Local antibiotic therapy; Osteomyelitis; Resorbable bone void filler

Indexed keywords

EID: 84984863755     PISSN: None     EISSN: 20463758     Source Type: Journal    
DOI: 10.1302/2046-3758.37.2000301     Document Type: Article

References (30)

1. Senthi S, Munro JT, Pitto RP. Infection in total hip replacement: meta-analysis. Int Orthop 2011;35:253-260.
2. Trampuz A, Zimmerli W. Diagnosis and treatment of implant-associated septic arthritis and osteomyelitis. Curr Infect Dis Rep 2008;10:394-403.
3. Zilberman M, Elsner JJ. Antibiotic-eluting medical devices for various applications. J Control Release 2008;130:202-215.
4. Wahlig H, Dingeldein E, Bergmann R, Reuss K. The release of gentamicin from polymethylmethacrylate beads: an experimental and pharmacokinetic study. J Bone Joint Surg [Br] 1978;60-B:270-275.
5. Henry SL, Galloway KP. Local antibacterial therapy for the management of orthopaedic infections. Pharmacokinetic considerations. Clin Pharmacokinet 1995;29:36-45.
6. Härle A, Ritzerfeld W. The release of gentamycin into the wound secretions from polymethylmethacrylate beads. A study with reference to the animal experiment. Arch Orthop Trauma Surg 1979;95:65-70.
7. Winkler H. Rationale for one stage exchange of infected hip replacement using uncemented implants and antibiotic impregnated bone graft. Int J Med Sci 2009;6:247-252.
8. Zalavras CG, Patzakis MJ, Holtom P. Local antibiotic therapy in the treatment of open fractures and osteomyelitis. Clin Orthop Relat Res 2004;427:86-93.
9. Klemm K. Treatment of chronic bone infection with gentamicin PMMA-chains and beads. Accid Surg 1976;1:20-25.
10. Klemm K. Gentamicin-PMMA-beads in treating bone and soft tissue infections. Zentralbl Chir 1979;104:934-942.[Article in German].
11. Klemm KW. Gentamicin-PMMA chains (Septopal chains) for the local antibiotic treatment of chronic osteomyelitis. Reconstr Surg Traumatol 1988;20:11-35.
12. McKee MD, Li-Bland EA, Wild LM, Schemitsch EH. A prospective, randomized clinical trial comparing an antibiotic-impregnated bioabsorbable bone substitute with standard antibiotic-impregnated cement beads in the treatment of chronic osteomyelitis and infected nonunion. J Orthop Trauma 2010;24:483-490.
13. Thomas MV, Puleo DA. Calcium sulfate: Properties and clinical applications. J Biomed Mater Res B Appl Biomater 2009;88:597-610.
14. de Boer HH. The history of bone grafts. Clin Orthop Relat Res 1988;226:292-298.
15. Kelly CM, Wilkins RM, Gitelis S, et al. The use of a surgical grade calcium sulfate as a bone graft substitute: results of a multicenter trial. Clin Orthop Relat Res 2001;382:42-50.
16. Bösebeck H, Büchner H. In: Peters KM, König DP, ed. Fortbildung Osteologie 3. 1st ed. Berlin Heidelberg: Springer-Verlag, 2010:109-115. [in German].
17. Coetzee AS. Regeneration of bone in the presence of calcium sulfate. Arch Otolaryngol 1980;106:405-409.
18. Peters CL, Hines JL, Bachus KN, Craig MA, Bloebaum RD. Biological effects of calcium sulfate as a bone graft substitute in ovine metaphyseal defects. J Biomed Mater Res A 2006;76:456-462.
19. McKee MD, Wild LM, Schemitsch EH, Waddell JP. The use of an antibiotic-impregnated, osteoconductive, bioabsorbable bone substitute in the treatment of infected long bone defects: early results of a prospective trial. J Orthop Trauma 2002;16:622-627.
20. Beuerlein MJ, McKee MD. Calcium sulfates: what is the evidence? J Orthop Trauma 2010;24(Suppl1):S46-S51.
21. Mousset B, Benoit MA, Delloye C, Bouillet R, Gillard J. Biodegradable implants for potential use in bone infection. An in vitro study of antibiotic-loaded calcium sulphate. Int Orthop 1995;19:157-161.
22. Lee GH, Khoury JG, Bell JE, Buckwalter JA. Adverse reactions to OsteoSet bone graft substitute, the incidence in a consecutive series. Iowa Orthop J 2002;22:35-38.
23. Robinson D, Alk D, Sandbank J, Farber R, Halperin N. Inflammatory reactions associated with a calcium sulfate bone substitute. Ann Transplant 1999;4:91-97.
24. Franceschini M, Di Matteo A, Bösebeck H, Büchner H, Vogt S. Treatment of a chronic recurrent fistulized tibial osteomyelitis: administration of a novel antibiotic-loaded bone substitute combined with a pedicular muscle flap sealing. Eur J Orthop Surg Traumatol 2012;22(Suppl1):245-249.
25. Saklad M. Grading of patients for surgical procedures. Anesthesiology 1941;2:281-284.
26. Mak PH, Campbell RC, Irwin MG. The ASA Physical Status Classification: interobserver consistency (American Society of Anesthesiologists). Anaesth Intensive Care 2002;30:633-640.
27. Gauland C. Managing lower-extremity osteomyelitis locally with surgical debridement and synthetic calcium sulfate antibiotic tablets. Adv Skin Wound Care 2011;24:515-523.
28. König DP, Schierholz JM, Hilgers RD, et al. In vitro adherence and accumulation of Staphylococcus epidermidis RP 62 A and Staphylococcus epidermidis M7 on four different bone cements. Langenbecks Arch Surg 2001;386:328-332.
29. Anagnostakos K, Hitzler P, Pape D, Kohn D, Kelm J. Persistence of bacterial growth on antibiotic-loaded beads: is it actually a problem? Acta Orthop 2008;79:302-307.
30. Neut D, de Groot EP, Kowalski RS, et al. Gentamicin-loaded bone cement with clindamycin or fusidic acid added: biofilm formation and antibiotic release. J Biomed Mater Res A 2005;73:165-170.